Company Filing History:
1 out of 4 
1 out of 832,843 Years Active: 2017-2021
Title: Mathias Dreger: Innovator in Medicinal Chemistry
Introduction
Mathias Dreger is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for the treatment of neurological disorders. With a focus on innovative solutions, Dreger has been awarded 2 patents for his groundbreaking work.
Latest Patents
Dreger's latest patents include the development of bicyclic compounds for use as a medicament, specifically targeting Parkinson's disease. This invention relates to novel small molecule compounds that inhibit the enzyme Catechol-O-methyltransferase (COMT) and exhibit a low off-target profile. The compounds are designed for use in the prevention or treatment of Parkinson's disease. Another significant patent involves a method for tagging, identifying, and isolating target cells using a capture compound that selectively binds to the cell surface. This innovative approach enhances the ability to isolate specific cells for further study.
Career Highlights
Throughout his career, Mathias Dreger has worked with various companies, including Caprotec Bioanalytics GmbH. His expertise in medicinal chemistry has allowed him to contribute to advancements in drug development and therapeutic applications.
Collaborations
Dreger has collaborated with notable professionals in his field, including Michael Sefkow and Hubert Koester. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Mathias Dreger's contributions to medicinal chemistry and his innovative patents highlight his commitment to advancing healthcare solutions. His work continues to impact the treatment of neurological disorders, showcasing the importance of innovation in medicine.